Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

35.61
+1.313.82%
Pre-market: 35.810.2000+0.56%06:50 EDT
Volume:17.34M
Turnover:633.05M
Market Cap:13.74B
PE:-3.84
High:37.91
Open:34.47
Low:33.93
Close:34.30
Loading ...

Stock Track | Moderna Pre-market Plunge of 5.1% Amid Analyst Price Target Cut

Stock Track
·
06 Mar

Why Moderna, Inc. (MRNA) Went Up on Wednesday

Insider Monkey
·
06 Mar

Berenberg Adjusts Price Target on Moderna to $30 From $33, Keeps Hold Rating

MT Newswires Live
·
06 Mar

Moderna Down 2.4% Premarket After 15.9% Rise on Wednesday; Berenberg Cuts PT to $30 From $33

THOMSON REUTERS
·
06 Mar

Equity Markets Rise as Trump Exempts Auto Makers From Tariffs

MT Newswires Live
·
06 Mar

Dow surges 500 points on hopes of tariff relief

Quartz
·
06 Mar

Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents

Reuters
·
06 Mar

Why Moderna (MRNA) Stock Is Rallying Today

Insider Monkey
·
06 Mar

Moderna Scores Legal Victory Over Pfizer, BioNTech in Patent Dispute

GuruFocus.com
·
06 Mar

Moderna Says Individualized Neoantigen Therapy on Track for 2027 Potential Approval

MT Newswires Live
·
06 Mar

Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court

MT Newswires Live
·
06 Mar

German Court Rules Pfizer, BioNTech, Violated Moderna Covid-19 Vaccine Patent, Reuters Reports

Dow Jones
·
06 Mar

Stock Track | Moderna Soars 11.13% as CEO's $5 Million Stock Purchase Boosts Confidence

Stock Track
·
05 Mar

German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent

Reuters
·
05 Mar

Moderna Shares Surge 10% After CEO Stephane Bancel Purchases $5 Million In Company Stock

Tiger Newspress
·
05 Mar

German Court Rules in Favour of Moderna in Patent Lawsuit Against BioNTech and Pfizer

THOMSON REUTERS
·
05 Mar